Smith & Nephew SN…
USUSDSmith & Nephew SNATS Inc (US:SNNUF) — Industrial Specialties. Aantal beurzen waarop de aandelen van het bedrijf worden verhandeld: 2. Op deze pagina — koers en grafiek, dividenden, grootste aandeelhouders en historiek van het aantal aandelen.
Over het Bedrijf
- Website
- smith-nephew.com
- Sector
- Health Care · Industrial Specialties
- Hoofdkantoor
- London, United Kingdom
- CEO
- Roland Diggelmann
- Werknemers
- 11 000
- Opgericht
- 1856
- Uitstaande Aandelen
- 418.52 mln. per 2025-12-31
- Free Float
- 2.11 mld.
- Marktkapitalisatie
- 11.12 mld. USD
- Insiders
- 0.01%
- Institutionele Beleggers
- 11.49%
- Branche (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Rechtsvorm
- B6ES
- ISIN
- GB0009223206
- LEI
- 213800ZTMDN8S67S1H61
- Uitkeringsratio
- 52.8%
- FCF
- 1.29 mld. USD
- Uitkering / FCF
- 26%
- Schuld
- 3.19 mld. USD2.1 jr FCF
- Dividendreeks
- 26 jr
- Winst, FCF en uitbetaalde dividenden — voor de 12 maanden tot 31.12.2025 (het laatste rapport van het bedrijf).
Beschrijving
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Dividenden
Smith & Nephew SNATS Inc (SNNUF) keert twee keer per jaar dividend uit. Per jaar (12 maanden tot en met de laatst aangekondigde betaling): 0.3916 USD per aandeel (betalingen: 2). Dat is ongeveer 2.94% van de huidige aandelenkoers. Op basis van de betalingsgeschiedenis wordt de volgende ex-dividenddatum verwacht rond 02.04.2027. Ononderbroken dividendgeschiedenis: 26 jaar.
| Ex-Datum | Uitbetaling | Bedrag | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-10-02 | 2026-11-06 | 0.1560 USD | 1.2/3.0 % | halfjaarlijks | US:SNNUF |
| 2026-03-27 | 2026-05-27 | 0.1778 GBP | 1.5/2.4 % | halfjaarlijks | US:SNNUF |
| 2025-10-03 | 2025-11-07 | 0.1126 GBP | 0.9/2.2 % | halfjaarlijks | US:SNNUF |
| 2025-03-28 | 2025-05-28 | 0.1748 GBP | 1.6/2.6 % | halfjaarlijks | US:SNNUF |
| 2024-10-04 | 2024-11-08 | 0.1110 GBP | 1.0/2.5 % | halfjaarlijks | US:SNNUF |
| 2024-04-01 | 2024-05-22 | 0.2310 USD | 1.7/≈3.5 % | halfjaarlijks | US:SNNUF |
Grootste Aandeelhouders
| Houder | Belang | Aandelen | Rapportdatum |
|---|---|---|---|
| Bank Of America Securiti… | ≈2.39% | 10.04 mln. | 2026-07-20 |
| River Road Asset Managem… | 0.77% | 3.22 mln. | 2026-06-30 |
| Goldman Sachs Group Inc | 0.73% | 3.07 mln. | 2026-06-30 |
| Brandes Investment Partn… | 0.51% | 2.15 mln. | 2026-06-30 |
| Dimensional Fund Advisor… | 0.44% | 1.84 mln. | 2026-06-30 |
| LMR Partners LLP | 0.42% | 1.77 mln. | 2026-06-30 |
| Causeway Capital Managem… | 0.37% | 1.57 mln. | 2026-06-30 |
| Wells Fargo & Company | 0.33% | 1.38 mln. | 2026-06-30 |
| Todd Asset Management L… | 0.3% | 1.25 mln. | 2026-06-30 |
| Morgan Stanley | 0.29% | 1.2 mln. | 2026-06-30 |
| Bank of Montreal /CAN/ | 0.27% | 1.15 mln. | 2026-06-30 |
| BlackRock Investment Man… | ≈0.1% | 433 611 | 2025-11-14 |
| Fidelity Rutland Square… | 0.08% | 333 428 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0.07% | 297 661 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0.07% | 273 638 | 2026-07-31 |
| American Century ETF Tru… | 0.06% | 268 458 | 2026-08-31 |
| 2023 ETF Series Trust-Br… | 0.06% | 256 404 | 2026-06-30 |
| JNL Series Trust-JNL MUL… | 0.05% | 201 147 | 2026-06-30 |
| AMG Funds IV-AMG River R… | 0.04% | 186 814 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0.04% | 181 094 | 2026-07-31 |
| Buffalo Funds-Buffalo In… | 0.04% | 154 254 | 2026-06-30 |
| AMG Funds IV-AMG River R… | 0.04% | 150 211 | 2026-07-31 |
| Dhankhar (Ajay) | ≈0% | 18 460 | 2025-11-06 |
| Owen (Marc E) | ≈0% | 8 805 | 2025-08-22 |
| Kong (Garheng) | ≈0% | 3 000 | 2025-11-06 |
| Nath (Deepak S) | ≈0% | 2 842 | 2026-07-10 |
| Connolly (Paul) | ≈0% | 2 833 | 2026-07-10 |
| King (David) | ≈0% | 2 800 | 2025-08-19 |
| Schaffner (Scott) | ≈0% | 1 451 | 2026-07-10 |
| Ma (John) | ≈0% | 1 372 | 2025-08-22 |
